Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2022 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling, with the company already embedded in that growth, and the counterparties' trajectory being early and large relative to the company. Let's analyze the transcript. The call is about Orion Engineered Carbons, a carbon black producer. Management discusses their outlook, pricing, volumes, etc. Key points: - They discuss rubber contract negotiations, pricing gains, supply-demand dynamics. - They mention "on shoring of tire production" in North America, and "increase in European tire capacity" as drivers of demand. - They talk about their own capacity additions (new plant in China, expansion in acetylene-based conductive carbon). - They discuss their own capital spending, cash flow, etc. Do they narrate specific counterparties' own trajectories? They mention "customers" generally, but not specific named or identifiable counterparties with their own ramps, launches, etc. They mention "tire production" onshoring, but that's a broad industry trend, not a specific counterparty's build-out. They mention "Russian carbon black" flows, but that's a market condition. They do not describe specific customers' expansion plans, production schedules, or program phases. They talk about their own contract negotiations and pricing. The direction of explanation is their own actions and market conditions, not a report on someone else's growth. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.